Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis
PURPOSE: To report the results of carotid artery stenting (CAS) in symptomatic patients (stroke/transient ischemic attack) after recent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS). METHODS: Between January 2009 and July 2011, 28 consecutive patients (18 w...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Sage Publications
2013
|
| _version_ | 1797060664930336768 |
|---|---|
| author | Casana, R Halliday, A Bianchi, P Fresa, E Silani, V Parati, G Blengino, S Cireni, L Adobbati, L Calvillo, L Tolva, V |
| author_facet | Casana, R Halliday, A Bianchi, P Fresa, E Silani, V Parati, G Blengino, S Cireni, L Adobbati, L Calvillo, L Tolva, V |
| author_sort | Casana, R |
| collection | OXFORD |
| description | PURPOSE: To report the results of carotid artery stenting (CAS) in symptomatic patients (stroke/transient ischemic attack) after recent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS). METHODS: Between January 2009 and July 2011, 28 consecutive patients (18 women; mean age 66 years, range 42-82) underwent protected CAS for symptomatic carotid stenosis following recent PTCA that included bare or drug-eluting stents requiring uninterrupted dual antiplatelet therapy. Primary technical success, neurological complications, major adverse cardiovascular events, and death were evaluated at 30 days and over midterm follow-up. RESULTS: Technical success was 96%; 1 patient suffered a nonfatal major stroke (3.5% 30-day stroke rate) during the procedure. During a median 21.6-month follow-up, 4 (14%) patients died of myocardial infarction (all diabetic smokers with ejection fractions <40%), but there were no new neurological events. Estimated survival was 89.3% at 2 years. Further coronary interventions were performed in 2 diabetic patients with a body mass index >34 kg/m(2). CONCLUSION: This preliminary experience demonstrated that CAS is a reasonable, safe, and effective treatment for patients with symptomatic carotid artery stenosis who were recently treated with coronary stents requiring uninterrupted dual antiplatelet therapy. |
| first_indexed | 2024-03-06T20:20:19Z |
| format | Journal article |
| id | oxford-uuid:2d93f234-4f5c-4653-b170-f9863a82eb30 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:20:19Z |
| publishDate | 2013 |
| publisher | Sage Publications |
| record_format | dspace |
| spelling | oxford-uuid:2d93f234-4f5c-4653-b170-f9863a82eb302022-03-26T12:43:49ZCarotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2d93f234-4f5c-4653-b170-f9863a82eb30EnglishSymplectic Elements at OxfordSage Publications2013Casana, RHalliday, ABianchi, PFresa, ESilani, VParati, GBlengino, SCireni, LAdobbati, LCalvillo, LTolva, V PURPOSE: To report the results of carotid artery stenting (CAS) in symptomatic patients (stroke/transient ischemic attack) after recent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS). METHODS: Between January 2009 and July 2011, 28 consecutive patients (18 women; mean age 66 years, range 42-82) underwent protected CAS for symptomatic carotid stenosis following recent PTCA that included bare or drug-eluting stents requiring uninterrupted dual antiplatelet therapy. Primary technical success, neurological complications, major adverse cardiovascular events, and death were evaluated at 30 days and over midterm follow-up. RESULTS: Technical success was 96%; 1 patient suffered a nonfatal major stroke (3.5% 30-day stroke rate) during the procedure. During a median 21.6-month follow-up, 4 (14%) patients died of myocardial infarction (all diabetic smokers with ejection fractions <40%), but there were no new neurological events. Estimated survival was 89.3% at 2 years. Further coronary interventions were performed in 2 diabetic patients with a body mass index >34 kg/m(2). CONCLUSION: This preliminary experience demonstrated that CAS is a reasonable, safe, and effective treatment for patients with symptomatic carotid artery stenosis who were recently treated with coronary stents requiring uninterrupted dual antiplatelet therapy. |
| spellingShingle | Casana, R Halliday, A Bianchi, P Fresa, E Silani, V Parati, G Blengino, S Cireni, L Adobbati, L Calvillo, L Tolva, V Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title | Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title_full | Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title_fullStr | Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title_full_unstemmed | Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title_short | Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis |
| title_sort | carotid artery stenting in patients with acute coronary syndrome a possible primary therapy for symptomatic carotid stenosis |
| work_keys_str_mv | AT casanar carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT hallidaya carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT bianchip carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT fresae carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT silaniv carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT paratig carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT blenginos carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT cirenil carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT adobbatil carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT calvillol carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis AT tolvav carotidarterystentinginpatientswithacutecoronarysyndromeapossibleprimarytherapyforsymptomaticcarotidstenosis |